FRISCO,
Texas, March 29, 2024 /PRNewswire/ -- Baird
Medical Devices, Inc. ("Baird Medical" or the "Company"), a leading
microwave ablation ("MWA") medical device developer and provider in
China and the United States, today announced it has
been granted a new Class III certificate by the National Medical
Products Administration (NMPA) in China for its next generation Ceramic Thyroid
Ablation Needle for the treatment of thyroid nodules on
March 19, 2024.
The Ceramic Thyroid Ablation Needle utilizes rare earth ceramic
materials that deliver exceptional heat resistance, chemical
stability, and electrical insulation properties. These qualities
empower the ablation needle with precise thermal control during
surgeries, effectively minimizing postoperative complications and
ensuring the safety and efficacy of procedures.
The unique properties of ceramics facilitate a more uniform
distribution of energy within the tissue during Microwave Ablation
Treatments, mitigating the edge heating effects resulting from
reflection and refraction. With an estimated 30% increase in
mechanical strength derived from its robust material, the needle
offers enhanced flexibility and reliability during tissue
penetration, thereby improving operational accuracy and reducing
the risk of breakage, particularly in delicate procedures.
The characteristics of rare earth ceramics optimize heating,
resulting in more consistent microwave energy penetration, thorough
energy release, and a notable 20-30% estimated increase in overall
heating efficiency. Through the use of high-temperature sintering
technology and a precision connection to the needle shaft via
specialized processes, the ceramic needle's efficiency is further
enhanced.
"The introduction of the Ceramic Thyroid Ablation Needle
signifies another breakthrough innovation in the field of microwave
ablation and is a testament to our ongoing commitment to innovation
and research," said Ms. Haimei Wu, Founder and CEO of Baird
Medical. "We eagerly anticipate the positive impact of this
technology by enhancing the patient treatment experiences and
saving lives in the years to come."
In 2023, China's NMPA's issued
updates to the Medical Device Classification Catalog, and upgraded
the Classification of Microwave Ablation Devices from a Class II to
a Class III Certificate.
About Baird Medical
Established in 2012 and
headquartered in Guangzhou, China,
Baird Medical is a leading microwave ablation (MWA) medical device
manufacturer and provider in China
and the United States. Baird
Medical's proprietary medical devices are used for the treatment of
benign and malignant tumors including thyroid nodules, liver
cancer, lung cancer and breast lumps. Baird Medical is the first
company to obtain a Class III medical devices registration
certificate for MWA medical devices specifically indicated for
thyroid nodules in China. For more
information, please visit http://baidesz.com/.
Forward-Looking Statements
This communication contains
"forward-looking statements." Such statements include statements
concerning anticipated future events and expectations that are not
historical facts. All statements other than statements of
historical fact are statements that could be deemed forward-looking
statements. Forward-looking statements are typically identified by
words such as "believe", "expect", "anticipate", "intend",
"target", "estimate", "continue", "positions", "plan", "predict",
"project", "forecast", "guidance", "goal", "objective",
"prospects", "possible" or "potential" by future conditional verbs
such as "assume", "will", "would", "should", "could" or "may" or by
variations of such words or by similar expressions or the negative
thereof. Actual results may vary materially from those expressed or
implied by forward-looking statements based on a number of factors.
Readers are cautioned not to place undue reliance on these
forward-looking statements, which speak only as of the date on
which they are made. Baird Medical does not assume any obligation
to publicly update any forward-looking statement after it is made,
whether as a result of new information, future events or otherwise,
except as required by law.
Contacts
Investor Relations
Robin Yang, Partner
ICR, LLC
Phone: +1 (646) 308-1475
Email: BairdMedical.IR@icrinc.com
Public Relations
Brad Burgess, Senior Vice
President
ICR, LLC
Phone: +1 (646) 588-0383
Email: BairdMedical.PR@icrinc.com
View original
content:https://www.prnewswire.com/news-releases/baird-medical-granted-new-class-iii-certificate-by-chinas-nmpa-for-ceramic-thyroid-ablation-needle-302103543.html
SOURCE Baird Medical Devices, Inc.